BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27218445)

  • 1. Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo.
    Qvit N; Disatnik MH; Sho E; Mochly-Rosen D
    J Am Chem Soc; 2016 Jun; 138(24):7626-35. PubMed ID: 27218445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics.
    Qvit N; Kornfeld OS; Mochly-Rosen D
    Angew Chem Int Ed Engl; 2016 Dec; 55(50):15672-15679. PubMed ID: 27860071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death.
    Qvit N; Joshi AU; Cunningham AD; Ferreira JC; Mochly-Rosen D
    J Biol Chem; 2016 Jun; 291(26):13608-21. PubMed ID: 27129213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation.
    Churchill EN; Murriel CL; Chen CH; Mochly-Rosen D; Szweda LI
    Circ Res; 2005 Jul; 97(1):78-85. PubMed ID: 15961716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.
    Wu CY; Satapati S; Gui W; Wynn RM; Sharma G; Lou M; Qi X; Burgess SC; Malloy C; Khemtong C; Sherry AD; Chuang DT; Merritt ME
    J Biol Chem; 2018 Jun; 293(25):9604-9613. PubMed ID: 29739849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein kinase C delta following cerebral ischemia leads to release of cytochrome C from the mitochondria via bad pathway.
    Dave KR; Bhattacharya SK; Saul I; DeFazio RA; Dezfulian C; Lin HW; Raval AP; Perez-Pinzon MA
    PLoS One; 2011; 6(7):e22057. PubMed ID: 21789211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage.
    Ikeno F; Inagaki K; Rezaee M; Mochly-Rosen D
    Cardiovasc Res; 2007 Mar; 73(4):699-709. PubMed ID: 17234167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase.
    Siwko S; Mochly-Rosen D
    Int J Biochem Cell Biol; 2007; 39(5):978-87. PubMed ID: 17337233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury.
    Budas GR; Churchill EN; Mochly-Rosen D
    Pharmacol Res; 2007 Jun; 55(6):523-36. PubMed ID: 17576073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. δPKC interaction with the d subunit of F1Fo ATP synthase impairs energetics and exacerbates ischemia/reperfusion injury in isolated rat hearts.
    Walker M; Caldwell RW; Yoon Y; Nguyen TT; Johnson JA
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):232-40. PubMed ID: 26519110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb remote postconditioning alleviates cerebral reperfusion injury through reactive oxygen species-mediated inhibition of delta protein kinase C in rats.
    Wang Q; Zhang X; Ding Q; Hu B; Xie Y; Li X; Yang Q; Xiong L
    Anesth Analg; 2011 Nov; 113(5):1180-7. PubMed ID: 21865497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
    Tso SC; Qi X; Gui WJ; Wu CY; Chuang JL; Wernstedt-Asterholm I; Morlock LK; Owens KR; Scherer PE; Williams NS; Tambar UK; Wynn RM; Chuang DT
    J Biol Chem; 2014 Feb; 289(7):4432-43. PubMed ID: 24356970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fused protein of deltaPKC activation loop and PDK1-interacting fragment (deltaAL-PIF) functions as a pseudosubstrate and an inhibitory molecule for PDK1 when expressed in cells.
    Seki T; Irie N; Nakamura K; Sakaue H; Ogawa W; Kasuga M; Yamamoto H; Ohmori S; Saito N; Sakai N
    Genes Cells; 2006 Sep; 11(9):1051-70. PubMed ID: 16923125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site.
    Masini T; Birkaya B; van Dijk S; Mondal M; Hekelaar J; Jäger M; Terwisscha van Scheltinga AC; Patel MS; Hirsch AK; Moman E
    J Enzyme Inhib Med Chem; 2016; 31(sup4):170-175. PubMed ID: 27435185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
    Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR
    Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C delta mediates cerebral reperfusion injury in vivo.
    Bright R; Raval AP; Dembner JM; Pérez-Pinzón MA; Steinberg GK; Yenari MA; Mochly-Rosen D
    J Neurosci; 2004 Aug; 24(31):6880-8. PubMed ID: 15295022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.
    Qvit N; Lin AJ; Elezaby A; Ostberg NP; Campos JC; Ferreira JCB; Mochly-Rosen D
    Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma.
    Carbone D; De Franco M; Pecoraro C; Bassani D; Pavan M; Cascioferro S; Parrino B; Cirrincione G; Dall'Acqua S; Moro S; Gandin V; Diana P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.
    Chen L; Hahn H; Wu G; Chen CH; Liron T; Schechtman D; Cavallaro G; Banci L; Guo Y; Bolli R; Dorn GW; Mochly-Rosen D
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11114-9. PubMed ID: 11553773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.